Innlanz Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 23 shareholders own 97.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
79.8%	Jhon Shen	250,000,000	AU$2.5m	0%	no data
4.21%	Qiming Du	13,190,811	AU$131.9k	0%	no data
3.5%	Xiyao Sun	10,950,383	AU$109.5k	0%	no data
3.19%	Yongqiang Lu	10,000,000	AU$100.0k	0%	no data
0.86%	Aussia Pharmaceuticals Pty Ltd	2,700,000	AU$27.0k	0%	no data
0.81%	Liu Yun	2,536,236	AU$25.4k	0%	no data
0.8%	Ming Xu	2,500,000	AU$25.0k	0%	no data
0.64%	Liu Wei	1,999,910	AU$20.0k	0%	no data
0.64%	Zhixiong Li	1,996,000	AU$20.0k	0%	no data
0.32%	Tissa Wijesuriya	1,007,698	AU$10.1k	0%	no data
0.32%	Chen Li	1,000,000	AU$10.0k	0%	no data
0.32%	Jun Yan	1,000,000	AU$10.0k	0%	no data
0.32%	Lei Wang	1,000,000	AU$10.0k	0%	no data
0.32%	Weiqing Ye	1,000,000	AU$10.0k	0%	no data
0.27%	Xinjia Cui	855,600	AU$8.6k	0%	no data
0.24%	Yi Liu	764,000	AU$7.6k	0%	no data
0.16%	Lian Yuanbo	500,000	AU$5.0k	0%	no data
0.12%	Chuang Wang	384,667	AU$3.8k	0%	no data
0.064%	Riby Kuriachan	200,000	AU$2.0k	0%	no data
0.064%	Eldo Pappachan	200,000	AU$2.0k	0%	no data
0.053%	Theo Renard	166,666	AU$1.7k	0%	no data
0.053%	Peter French	166,666	AU$1.7k	0%	no data
0.019%	Leo Cui	61,000	AU$609.9	0%	no data